Known as the “Alzheimer’s of the eye,” AMD affects nearly five million people across the world. How a new blood-based test could help.
Known as the “Alzheimer’s of the eye,” AMD affects nearly five million people across the world. How a new blood-based test could help.
Findings from a recent study, published in the New England Journal of Medicine, lend insight into a possible new eye screening protocol.
Copyright 2024 | Mass General Research Institute | Disclaimer